# GUCA2B

## Overview
The GUCA2B gene encodes the protein uroguanylin, a peptide hormone that plays a significant role in the regulation of fluid and electrolyte balance within the gastrointestinal tract. Uroguanylin functions as an endogenous ligand for the guanylate cyclase-C (GC-C) receptor, which is pivotal in modulating intestinal ion transport and maintaining homeostasis. This protein is characterized by its small size and the presence of conserved cysteine residues that form disulfide bonds, essential for its structural integrity and function (Marcolino2016Structural). Uroguanylin is involved in various physiological processes, including satiety and intestinal barrier integrity, and has been implicated in clinical conditions such as hypertension and gastrointestinal disorders (Brenna2016Cellular; Rodríguez2016Guanylin). The gene's expression and regulation are of interest in metabolic research, particularly concerning obesity and related surgical interventions (FernandezCachon2018Guanylin).

## Structure
The GUCA2B gene encodes the uroguanylin protein, which is involved in regulating salt absorption processes. The mature uroguanylin peptide consists of 16 amino acids and is characterized by four conserved cysteine residues that form two disulfide bonds, specifically between Cys I and Cys III, and Cys II and Cys IV. These disulfide bonds are crucial for maintaining the peptide's loop structure, which is essential for its function (Marcolino2016Structural).

The structural analysis of uroguanylin has primarily focused on isoform A, which shares structural similarities with the E. coli heat-stable enterotoxin. This isoform is stabilized by its disulfide bonds, contributing to its compact and stable conformation (Marcolino2016Structural). The study of missense SNPs in the GUCA2B gene has revealed that certain variants can disrupt these disulfide bridges, leading to increased flexibility and potential functional changes in the protein (Marcolino2016Structural).

Due to the small size of the uroguanylin peptide, it is suitable for detailed molecular dynamics simulations, which have been used to assess the impact of genetic variants on its structural stability and flexibility (Marcolino2016Structural). The lack of a complete three-dimensional structure limits the full assessment of some variants' impacts (Marcolino2016Structural).

## Function
The GUCA2B gene encodes uroguanylin, a peptide hormone that plays a crucial role in maintaining fluid and electrolyte balance in the intestines. Uroguanylin functions as an endogenous ligand for the guanylate cyclase-C (GC-C) receptor, which is expressed throughout the intestinal epithelium from the duodenum to the colon. Upon binding to GC-C, uroguanylin increases intracellular cyclic guanosine monophosphate (cGMP) levels, leading to the activation of the cystic fibrosis transmembrane conductance regulator (CFTR). This activation results in the secretion of chloride and bicarbonate ions and the inhibition of the sodium-hydrogen exchanger (NHE3), promoting net water secretion into the intestinal lumen (Brenna2016Cellular).

Uroguanylin is involved in various physiological processes, including ion and fluid homeostasis, satiety, and intestinal barrier integrity. It is secreted into the gastrointestinal lumen and circulates systemically, suggesting a role in broader metabolic regulation. The GUCA2B gene is expressed in specific epithelial cells in the human duodenum and colon, with some cells exhibiting a tuft cell-like morphology, which may indicate sensory functions (Brenna2016Cellular). The GUCA2B gene's expression and function are also linked to the regulation of satiety and may have implications for obesity management (Rodríguez2016Guanylin).

## Clinical Significance
Mutations and alterations in the GUCA2B gene, which encodes the protein uroguanylin, have been linked to several clinical conditions. Missense single nucleotide polymorphisms (SNPs) in GUCA2B can lead to structural changes in the uroguanylin peptide, potentially affecting its function. These structural changes have been associated with diseases such as chronic renal failure, congestive heart failure, and nephrotic syndrome. Additionally, point mutations in uroguanylin have been linked to essential hypertension (Marcolino2016Structural).

Alterations in GUCA2B expression levels have also been observed in the context of obesity and Roux-en-Y gastric bypass (RYGB) surgery. Post-surgery, GUCA2B mRNA expression is significantly upregulated, suggesting a response to surgical intervention. However, despite increased expression, guanylins, including GUCA2B, do not significantly impact body weight regulation or glycemic control in obese patients (FernandezCachon2018Guanylin).

In the gastrointestinal tract, GUCA2B is involved in ion and fluid homeostasis. Dysregulation of GUCA2B and its signaling pathway has been implicated in conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), where it may affect epithelial barrier function and contribute to disease pathogenesis (Brenna2016Cellular; Tronstad2018Genetic).


## References


[1. (Rodríguez2016Guanylin) A Rodríguez, J Gómez-Ambrosi, V Catalán, S Ezquerro, L Méndez-Giménez, S Becerril, P Ibáñez, N Vila, M A Margall, R Moncada, V Valentí, C Silva, J Salvador, and G Frühbeck. Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes. International Journal of Obesity, 40(9):1405–1415, April 2016. URL: http://dx.doi.org/10.1038/ijo.2016.66, doi:10.1038/ijo.2016.66. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ijo.2016.66)

[2. (Brenna2016Cellular) Øystein Brenna, Marianne W. Furnes, Bjørn Munkvold, Mark Kidd, Arne K. Sandvik, and Björn I. Gustafsson. Cellular localization of guanylin and uroguanylin mrnas in human and rat duodenal and colonic mucosa. Cell and Tissue Research, 365(2):331–341, April 2016. URL: http://dx.doi.org/10.1007/s00441-016-2393-y, doi:10.1007/s00441-016-2393-y. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-016-2393-y)

[3. (Marcolino2016Structural) Antonio C.S. Marcolino, William F. Porto, Állan S. Pires, Octavio L. Franco, and Sérgio A. Alencar. Structural impact analysis of missense snps present in the uroguanylin gene by long-term molecular dynamics simulations. Journal of Theoretical Biology, 410:9–17, December 2016. URL: http://dx.doi.org/10.1016/j.jtbi.2016.09.008, doi:10.1016/j.jtbi.2016.09.008. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jtbi.2016.09.008)

[4. (FernandezCachon2018Guanylin) María L. Fernandez-Cachon, Søren L. Pedersen, Kristoffer T. Rigbolt, Chen Zhang, Katrine Fabricius, Henrik H. Hansen, Lisbeth Elster, Lisbeth N. Fink, Matthias Schäfer, Nicolai A. Rhee, Ebbe Langholz, Erik Wandall, Steffen U. Friis, Peter Vilmann, Viggo B. Kristiansen, Christina Schmidt, Kay Schreiter, Kristin Breitschopf, Thomas Hübschle, Tina Jorsal, Tina Vilsbøll, Thorsten Schmidt, Stefan Theis, Filip K. Knop, Philip Just Larsen, and Jacob Jelsing. Guanylin and uroguanylin mrna expression is increased following roux-en-y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control. Peptides, 101:32–43, March 2018. URL: http://dx.doi.org/10.1016/j.peptides.2017.12.024, doi:10.1016/j.peptides.2017.12.024. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.peptides.2017.12.024)

[5. (Tronstad2018Genetic) Rune R. Tronstad, Tatiana Polushina, Hans-Richard Brattbakk, Christine Stansberg, Hilde Løland von Volkmann, Kurt Hanevik, Eva Ellinghaus, Silje Fjellgård Jørgensen, Kari Merete Ersland, Khanh D.-C. Pham, Odd Helge Gilja, Nils Hovdenak, Trygve Hausken, Morten H. Vatn, Andre Franke, Per Morten Knappskog, Stephanie Le Hellard, Tom Hemming Karlsen, and Torunn Fiskerstrand. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with gucy2c-linked familial diarrhea. Scandinavian Journal of Gastroenterology, 53(10–11):1264–1273, October 2018. URL: http://dx.doi.org/10.1080/00365521.2018.1521867, doi:10.1080/00365521.2018.1521867. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/00365521.2018.1521867)